News
Hefty lab partners with Biotech Lab producing vaccines for Lyme disease and Chlamydia
Design-Zyme, KU collaboration results in $3 million SBIR award for Lyme disease vaccine development
Professor Jon Tunge named August 2024 Walter and Roy Cross Professional Service Award recipient
Kim, CBID research project leader, awarded $25,000
Sathyamoorthi, CBID research graduate, granted $76,500
Zückert awarded Chancellors Club Teaching Professorship
CBID pilot leader Baral's discovery could help treat fatal, drug-resistant pneumonia and sepsis
Farrell awarded patent for kifunensine analogs
Former CBID pilot project leader Ackley receives new award
Baral Granted $1.87 Million by NIH to explore cell interactions that fight inflammatory disease (Opens in new window)
Pankaj Baral, Kansas State University assistant professor and CBID Pilot Project leader, has been awarded a Maximizing Investigators' Research Award, or MIRA, by the National Institute of General Medical Sciences. This early stage investigator grant will fund his study of how immune cells and sensory neurons affect tissue inflammation...
5 CBID participants earn promotion and tenure
Congratulations to five CBID faculty who have earned promotion and tenure this spring. ...
KU announces 2024 Undergraduate Research Mentor Awards
Ferreira Awarded New Faculty Research Development Award
Rosana Ferreira, CBID Research Project leader, has been awarded a New Faculty Research Development Award for her project titled "Bacterial Interactions and Their Role in the Skin Microbiome Composition." This one year award provides $20,000 to support research development of her project. ...
Teruna Siahaan Awarded An NIH R01
Study reports new compound halting replication of COVID by targeting ‘Mac-1’ protein in cell models
Orozco, CBID Research Project Leader, Finds Gene that Enhances Anti-Viral Immunity (Opens in new window)
Robin Orozco, an assistant professor of Molecular Biosciences at the University of Kansas, has unveiled new research that explores how a common mutation in the human population changes immune response during a virus infection. Dr. Orozco recently published these findings in PLoS Pathogens and provided foundational building blocks for researchers...
Siahaan and Fehr recognized as 2023 KU innovators (Opens in new window)
KU and its medical center are filled with great innovators striving to find creative solutions for the problems facing our world. Today, the KU Center for Technology Commercialization wants to thank all members of KU's research community for their creativity and ingenuity. We also wish to show specific appreciation to...
Hefty elected to NAIPI National Committee (Opens in new window)
Congratulations to Dr. Scott Hefty, CBID Program Director, for being elected to the National Committee of the National Association of IDeA Principal Investigators (NAIPI). The mission of NAIPI is to provide leadership and communication for the development, promotion and improvement of biomedical research through the INBRE, COBRE, and CTR IDeA...
Hefty elected to NAIPI National Committee
Congratulations to Dr. Scott Hefty, CBID Program Director, for being elected to the National Committee of the National Association of IDeA Principal Investigators (NAIPI). NAIPI aims to protect and promote the IDeA programs. It fosters interactions, promotes resource sharing, enhances the national visibility of the INBREs, CoBREs, and CTRs, develops...
Lynn Hancock Awarded Newest CBID Pilot Project
Lynn Hancock, Associate Professor, Department of Molecular Biosciences, University of Kansas, is the new recipient of a CBID pilot project award. Dr. Hancock's project title is “Glycobiology at the interface of the host-microbe interaction." ...
Davido Granted $289,300 by NIH
David Davido, Professor of Molecular Biosciences, has been awarded an NIH supplement grant. This one year award totals $289,300 for Identifying Novel Inhibitors of HSV-2 ICP0. ...
New grasp of key COVID-19 protein may lead to a live-attenuated vaccine effective against more variants for longer
LAWRENCE — Research from the University of Kansas just published in Proceedings of the National Academy of Sciences could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19. ...
Grant Will Fund Research Into Antibiotic Resistance (Opens in new window)
Joanna Slusky, Associate Professor in the Department of Molecular Biosciences at the University of Kansas, received a four-year grant from the National Institute of General Medical Sciences with a total cost of $1,244,968. The NIH funded study, entitled “Plugging & Pulling-in: tuning peptides for ToIC to overcome antibiotic resistance” will...
KU chancellor announces promotion and tenure for 163 faculty and researchers
LAWRENCE — Chancellor Douglas A. Girod has approved the promotion and award of tenure, where indicated, for 64 individuals at the University of Kansas Lawrence and Edwards campuses and 99 individuals at the KU Medical Center campuses. ...
Fehr, CBID Faculty Recruit, Published New PNAS Article
Congratulations to Dr. Anthony Fehr, Molecular Biosciences, for his most recent publication. ...
Dataset revolutionizes understanding of beta barrels, promising targets for vaccine development
LAWRENCE — Examples of infections tied to gram-negative bacteria include pneumonia, bloodstream infections, wound-site infections and meningitis, according to the Centers for Disease Control and Prevention. ...
Slusky, CBID Pilot Project Awardee, Granted $311,242 by NIH
Dr. Joanna Slusky, CBID Pilot Project Awardee, has been granted an R01 award by the National Institutes of Health. This three year award totals $311,242 and is titled "Plugging & Pulling-in: tuning peptides for ToIC to overcome antibiotic resistance". ...
Slusky, CBID Pilot Project Leader, has article accepted by PNAS
Dr. Joanna Slusky, Molecular Biosciences, had an article published in PNAS today. ...
Farrell, CBID Research Project Awardee, Granted $1,912,500 by NIH (Opens in new window)
Dr. Mark Farrell, Assistant Professor of Medicinal Chemistry, was granted a National Institutes of Health award for $1,912,500. Titled "Glycoscience Tools and Therapeutics, this five year award is part of the R35 program known as the Outstanding Investigator Award. ...